Transpire Bio Announces R&D And Manufacturing Expansion
“As we continue to advance our pipeline of innovative inhaled therapeutics for pulmonary and systemic diseases with high unmet medical needs, we will be expanding our R&D and commercial manufacturing capabilities,” said Dr. Xian-Ming Zeng, Chief Executive Officer of Transpire Bio.“The new facility will significantly increase our manufacturing capacity to enable us to manufacture the inhalation medicines we are developing in the US. We are pleased to secure the space needed in South Florida, as it allows for seamless integration with our other facilities and increases our presence in this dynamic community.”
About Transpire Bio Inc.
Transpire Bio Inc. is an integrated US-based, clinical-stage biopharmaceutical company headquartered in Sunrise, Florida. Transpire Bio harnesses its inhaled drug delivery expertise to improve patients' lives by expanding access to important therapies and developing treatments for serious diseases where therapeutic options are significantly lacking. Transpire Bio is developing multiple proprietary inhalation technology platforms, including dry powder inhalers, soft-mist inhalers, and metered-dose inhalers.
For more information, please visit
For Media & Investor Inquiries
Stuart Loesch
...
...
+1 954.908.2233


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- NOVA Collective Invest Showcases Intelligent Trading System7.0 Iterations Led By Brady Rodriguez
- 1Inch Unlocks Access To Tokenized Rwas Via Swap API
- Ethereum-Based Meme Project Pepeto ($PEPETO) Surges Past $6.5M In Presale
- USDT0 And Xaut0 Are Now Live On Polygon
- Falcon Finance Announced $FF And Community Sale On Buidlpad
- Japan Halal Food Market Size To Surpass USD 323.6 Billion By 2033 With A CAGR Of 8.1%
Comments
No comment